Pages that link to "Q34115785"

The following pages link to Identification of a psoriasis susceptibility candidate gene by linkage disequilibrium mapping with a localized single nucleotide polymorphism map. (Q34115785):

Displaying 41 items.

• A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci (Q21145042) (← links)
• Psoriasis genetics: breaking the barrier (Q24629796) (← links)
• Psoriasis pathophysiology: current concepts of pathogenesis (Q24674984) (← links)
• A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes (Q24680489) (← links)
• Collecting a set of psoriasis family material through a patient organisation; clinical characterisation and presence of additional disorders. (Q24816472) (← links)
• Molecular physiology of cation-coupled Cl? cotransport: the SLC12 family (Q28203488) (← links)
• Identification and characterization of novel variants of the thioredoxin reductase 3 new transcript 1 TXNRD3NT1. (Q31144022) (← links)
• Detection of genotyping errors by Hardy-Weinberg equilibrium testing. (Q33197920) (← links)
• ADAM33, a new candidate for psoriasis susceptibility (Q33299472) (← links)
• Early gene changes induced by isotretinoin in the skin provide clues to its mechanism of action (Q33716949) (← links)
• Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities (Q34327203) (← links)
• Single nucleotide polymorphism seeking long term association with complex disease (Q34366761) (← links)
• Genetics of psoriasis: the potential impact on new therapies (Q34535908) (← links)
• Genome-based pharmacogenetics and the pharmaceutical industry (Q34743245) (← links)
• SNPs--where's the beef? (Q35002542) (← links)
• The further evolution of biotech (Q35037675) (← links)
• Aberrant signalling and transcription factor activation as an explanation for the defective growth control and differentiation of keratinocytes in psoriasis: a hypothesis (Q35203839) (← links)
• The future of genetic testing for drug response. (Q35236756) (← links)
• The genetic basis of spondyloarthritis (Q35688995) (← links)
• Pharmacogenetics and drug development: the path to safer and more effective drugs (Q35889605) (← links)
• The immunogenetics of asthma and eczema: a new focus on the epithelium (Q35968476) (← links)
• Disease-specific target selection: a critical first step down the right road (Q36039820) (← links)
• Understanding the pathogenesis of psoriasis, psoriatic arthritis, and autoimmunity via a fusion of molecular genetics and immunology (Q36232663) (← links)
• Getting under the skin: the immunogenetics of psoriasis (Q36247085) (← links)
• Psoriasis: genetic associations and immune system changes. (Q36648696) (← links)
• Various pharmacogenetic aspects of antiepileptic drug therapy: a review (Q36729620) (← links)
• Current understanding of human genetics and genetic analysis of psoriasis (Q37986834) (← links)
• Putative biomarker genes for grading clear cell renal cell carcinoma (Q39506484) (← links)
• Characterisation of psoriasis susceptibility locus 6 (PSORS6) in patients with early onset psoriasis and evidence for interaction with PSORS1. (Q40862474) (← links)
• An association study of 22 candidate genes in psoriasis families reveals shared genetic factors with other autoimmune and skin disorders (Q42625730) (← links)
• Genetics of common chronic inflammatory skin diseases : An update on atopic dermatitis and psoriasis (Q44066217) (← links)
• Association analysis of the skin barrier gene cystatin A at the PSORS5 locus in psoriatic patients: evidence for interaction between PSORS1 and PSORS5. (Q46683887) (← links)
• Genetics of psoriasis: evidence for epistatic interaction between skin barrier abnormalities and immune deviation. (Q47722484) (← links)
• Dense linkage disequilibrium mapping in the 15q11-q13 maternal expression domain yields evidence for association in autism (Q47771802) (← links)
• Paradoxical psoriasiform reactions to anti-TNFα drugs are associated with genetic polymorphisms in patients with psoriasis (Q50439934) (← links)
• Application of genomewide SNP arrays for detection of simulated susceptibility loci. (Q51592927) (← links)
• Replication of LCE3C–LCE3B CNV as a Risk Factor for Psoriasis and Analysis of Interaction with Other Genetic Risk Factors (Q57304570) (← links)
• Association scan of the novel psoriasis susceptibility region on chromosome 19: evidence for both susceptible and protective loci (Q57990849) (← links)
• Expression and potential role of cellular retinol binding protein I in psoriasis (Q60919964) (← links)
• Serum levels of interleukin-18 and s-ICAM-1 in patients affected by psoriasis: preliminary considerations (Q73041109) (← links)
• Slc12a8 is a nicotinamide mononucleotide transporter (Q92309613) (← links)